• Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • About
    • About Us
    • Founding Team
  • Blog
  • Drug Search
  • Zones
    • Suicide
    • Violence
    • Sex and Relationships
    • Hair
    • Skin and Nails
    • Withdrawal
    • Vision
    • Fertility
  • Research Fund
  • Tools
    • Healthcare Record Pro Forma
    • Starting a Medication
    • Guides & Papers
    • Too Many Medications?
    • Complex Withdrawal
    • Videos
    • Reducing the Risk of Treatment Induced Suicide
  • PSSD
    • Post-SSRI Sexual Dysfunction (PSSD)
    • PSSD Doctors
    • PSSD Literature
    • PSSD in the Media
    • RxISK Prize
    • Research Forum for Enduring Sexual Dysfunction
  • Side Effect?
RxISK Logo

RxISK

Making Medicines Safer for All of Us

Whose Fault Are Suicides?

November 16, 2026 Leave a Comment

This post gets its title from the image above by Paul Klee called Whose Fault Is It.  This image is not as simple as it looks – Klee was persecuted by the Nazis.

The post links to Girls Who Walk on Water  and earlier RxISK posts like  Is Your Treatment Making you Suicidal inspired by Katinka Newman’s efforts to raise awareness of these issues and another  Antidepressant Injury Petition  currently underway driven by Kim Witczak.

Four weeks ago MHRA announced new warnings on antidepressants for suicide and sexual dysfunction, RxISK covered this –  MHRA announce Warnings – focusing more on the sexual dysfunction than the suicide issues in great part because there was some movement on the sexual dysfunction front but little beyond window dressing on the suicide front.  MHRA themselves said they were doing nothing new:

“The aim is not to discourage use,
but to improve the prominence and clarity of the existing warnings.”

BMJ also covered MHRA’s Warnings focusing more on sex. It’s a bland News item that says almost nothing. The bland article is behind a paywall – so we’ve linked it above.

We missed an extraordinary response. The response is open access but we are reproducing it in full below.

Why?  Read and spread.

Rashmi Jadon

The letter is by Rashmi Jadon, who tells you more about herself below.  It has the economy, simplicity and force of Abraham Lincoln’s Gettysburg Address. This is no exaggeration.

She has spent time researching the responses of medical colleagues to adverse events. All of the people she has interviewed on the family medicine coalface appear genuinely decent people.  Life is made difficult for them by MHRA, NICE, the Royal Colleges of Psychiatrists and General Practitioners and a general climate of adverse event dismissal and denial, one of the latest features of which is Functional Neurological Disorder – see the Rise and Rise of FND and Neurologists Functional Disorder.

The responses from family medicine contrasted strongly with the responses she had from Partialists – presidents of Royal Colleges, Ennobled folk, the people who get interviewed by the media. Their responses shocked and are shocking.

Dear Editor

The MHRA’s decision to strengthen warnings regarding SSRI-induced suicide is a positive step towards improving patient safety. However, for these warnings to truly mitigate risks that have cost numerous lives for over three decades, widespread education across healthcare systems must follow. Over 30,000 deaths by SSRI- and SNRI-related suicide are recorded across pharmacovigilance databases (1-3) a likely significant underestimate.

Although I do not prescribe SSRIs as an oncology consultant, I see several parallels to my own practice. I prescribe chemotherapy, which benefits some, but can seriously harm others. The public perceive chemotherapy to be “life-saving”; in reality these drugs rarely cure cancer on their own. The average person has manageable side effects, yet a proportion of people suffer horrifically, sometimes resulting in death.

Risk-benefit conversations need to be held prior to starting treatment. In particular failing to warn about the risk of neutropenic sepsis, and the resultant risk of death (approximately 2% for solid cancers) would be considered clinically and legally indefensible. Failure to warn a patient commencing SSRIs that they could become suicidal is no different. While it can be argued that high-volume primary care bears no resemblance to tertiary oncology, the principles of informed consent and risk management remain the same.

In oncology, warning cards for neutropenic sepsis are a successful intervention, which reduce door-to-needle time for receiving life-saving intravenous antibiotics (4). Their importance is recognised internationally, and these cards are put directly into the hand of each patient by the prescriber when risk-benefit conversations are held.

The success of neutropenic sepsis warning cards hinges on: prescribers believing that this risk is real, the risk being clearly and repeatedly communicated to the patient, and most importantly that emergency and acute services can recognise and manage this complication.

For MHRA’s plan to use warning cards to succeed, three components must be considered:

1. Prescribers must believe SSRI-related suicide is a real risk.

The emergence of suicidality on commencing or withdrawing from SSRIs is not a progression of underlying depression, but a drug reaction, and this distinction must be made. This has been reported in healthy volunteers, where suicidality occurred on SSRI initiation in the absence of any mental health problems (5).

GPs commonly advise patients when prescribing that they should expect to “feel worse before they feel better”. This narrative risks patients not reporting severe adverse events and must be re-considered. Importantly prescribers are not trained to recognise akathisia – a drug reaction that presents with a sense of inner terror, inability to sit still, insomnia, and dysphoria (6,7) which often precedes suicidal behaviours.

If suicidality or akathisia are unrecognised as drug reactions, patients are advised to persist with SSRI in hope of a positive response at 4-6 weeks- the results could be catastrophic–prescribing cascades, psychiatric admissions, or even death.

2. Prescribers must communicate the risk of suicidality directly to patients

Prescribers must communicate the risk of suicidality directly to patients before commencing the medication, rather than leaving them to find an information leaflet or warning card. The risk should be re-iterated on review or when changing doses.

3. The warning card urges patients to seek immediate help.

However, a major systemic failure remains: if a patient contacts their doctor, attends A&E or calls NHS 111, Samaritans, or SHOUT, none of these frontline agencies are currently trained to understand medication-induced suicidality. They are trained to see suicidality as a progression of underlying psychiatric illness, not as an acute adverse drug event.

Without updates to front-line clinician education, helpline training, and guidance on how to manage SSRI induced suicidality these vital new warnings may fail to achieve their life-saving potential.

References:

1. US FDA. FAERS Database. https://www.fda.gov/drugs Accessed January 2026.
2. EMA. EudraVigilance Database. https://www.ema.europa.eu/en/ Accessed January 2026.
3. MHRA. Yellow Card Scheme. https://yellowcard.mhra.gov.uk/idaps Accessed January 2026.
4. Botten J, Beard J, Zorzi A, Thompson A. A simple intervention to improve antibiotic treatment times for neutropenic sepsis. Acute Med. 2016;15(1):3-6. PMID: 27116580.
5. Healy D, Emergence of antidepressant induced suicidality; Primary Care Psychiatry 2000; 6:23–28
6. Koliscak LP, Makela EH. Selective serotonin reuptake inhibitor-induced akathisia. J Am Pharm Assoc (2003). 2009 Mar-Apr;49(2):e28-36.
7. MISSD Foundation (2021) Akathisia in their own words

Whose Fault Is It

Above MHRA said:

“The aim is not to discourage use,
but to improve the prominence and clarity of the existing warnings.”

Regulators (FDA – MHRA) say prescription medicines are unavoidably hazardous. On this basis it is not clear how this MHRA statement computes. It does not make sense to encourage the use of unavoidably hazardous medicines.

It only computes if it is not MHRA’s or FDA’s job to say anything about whether any of us should or should not be taking these chemicals.

Whatever about the effects on us, taking the hazardous chemicals makes Pharma healthier. They do a lot to avoid discouraging us – like writing non-discouraging labels that regulators approve.

Pharma also ghostwrite the articles on which the guidelines that make their drugs the number one treatment option are based. The guidelines close to mandate having a prescription written for drug X, Y or Z before the person walks in the door. Guideline agencies know the articles are ghostwritten, the data are hearsay – they have no access to them, and many of the articles are fraudulent. But they say nothing because deterring you is not part of the job of guideline writers.

The system is heavily conflicted – but we know that don’t we.

In 1951, new unavoidably hazardous drugs that could save lives were made prescription-only. The thinking was that a doctor’s lived professional experience would counterbalance the conflicts that plagued those scurvy Pharma knaves.  Doctors were given, in principle, an interest that conflicted with Pharma’s. For us to maintain the faith that we had in them that led us to consult them even when the new drugs were available over the counter (OTC) they had to continue to offer us something that was a better bet than trusting our own instincts.

It doesn’t seem to have occurred to politicians that giving doctors police powers over us – that’s what prescription-only began life as – might not be a good idea.  It doesn’t seem to have occurred to legislators that trapping us into having to see doctors might remove all incentive for these doctors to look after us.  It doesn’t seem to have occurred to anyone (except pharma) that all of a sudden legislation had made doctors the consumers of drugs and allowed pharma to lavish more money per head on each of them that gets spent on marketing to any other group of consumers on earth,

It’s currently close to impossible to view prescription antidepressants as safer than they’d be OTC. Nobody takes OTC medicines that don’t feel like they suit. Doctors telling us to continue SSRIs no matter how bad we feel – kill us.

This is not the same with cancer drugs. So hazardous are oncologics, you’d imagine their labels would be 5 times longer than SSRI labels – but it’s the other way around.  We don’t need labels to tell us oncologics are hazardous. Oncologists see their drugs killing people and put Us not Pharma first. SSRI labels in contrast are viewed as like May Contain Nuts labels – just companies covering their backs.

Rashmi is right to say that doctors and everyone linked to mental healthcare needs to be seized by something like the spirit that motivates oncologists. But who is going to get this to happen.

When it comes to psychotropic drugs, whether generalists or partialists, prescribers behave like medical students waiting for someone to tell them what to think rather than as the professionals who have learnt from seeing what happens when unavoidably hazardous chemicals kill people who should never have died.

A century ago, Max Weber said countries need leaders – they cannot be governed by bureaucrats (i.e. regulators and guideline writers).  Leaders, he said, need to be like doctors, who are willing to intervene when needed and take responsibility for the advice they give. It’s inconceivable that he would suggest leaders should be like today’s doctors – oncologists excepted.

Doctors need to rediscover the Right Stuff.  They need to stop swallowing Probity Blockers and get back to practicing CiS-Medicine. Regulators and other bureaucrats or political ‘leaders’ are not going to do it for them.

It is difficult to believe anyone would go near an oncologist if they were likely to die earlier from seeing one.  Those of us being treated by mental health services in general lose 20 years of life expectancy.  We had the same life expectancy as the rest of the population before the introduction of psychotropic drugs. The tragedy is these same drugs have the capacity to do great good.

The good that these medicines can do does not lie in the medicine, anymore than the good guns or missiles can do – good is something we bring out of the tools we use and in this case unless it involves me swallowing on OTC medicine it needs a decent relationship.

It’s our doctors not our drugs that are failing us. Why are we tolerating this?

Women – Rashmi, Kim and Katinka – not men are leading the way in saying enough is enough.

Filed Under: Antidepressants, Suicide, Violence, Withdrawal

Are you experiencing a drug side effect?

Get your free RxISK Report to find out

 

Subscribe to our mailing list
Get notified when we publish a new blog post.
By subscribing, you agree with our privacy policy and our terms of service.

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

Recent Posts

  • Whose Fault Are Suicides?
  • The Rise and Rise of Functional Neurological Disorder
  • Ariadne’s Thread and Post-Mefloquine Toxicity
  • MHRA Announces New Warnings for Suicide and PSSD
  • The Troubled Dream of Life

Blog Categories

Footer

Contact

Media Contact

Terms | Privacy

Follow us

  • Facebook
  • Twitter

Search

Copyright © 2026 · Data Based Medicine Global Ltd.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.